Geode Capital Management’s Astrana Health ASTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $54.2M | Buy |
1,167,974
+129,889
| +13% | +$4.67M | ﹤0.01% | 1579 |
|
|
2026
Q1 | $25.5M | Buy |
1,038,085
+9,917
| +1% | +$235K | ﹤0.01% | 1866 |
|
|
2025
Q4 | $25.5M | Buy |
1,028,168
+12,212
| +1% | +$324K | ﹤0.01% | 1878 |
|
|
2025
Q3 | $28.8M | Sell |
1,015,956
-37,380
| -4% | -$1.01M | ﹤0.01% | 1814 |
|
|
2025
Q2 | $26.2M | Sell |
1,053,336
-13,805
| -1% | -$389K | ﹤0.01% | 1822 |
|
|
2025
Q1 | $33.1M | Buy |
1,067,141
+50,366
| +5% | +$1.68M | ﹤0.01% | 1612 |
|
|
2024
Q4 | $32.1M | Sell |
1,016,775
-1,243
| -0.1% | -$59K | ﹤0.01% | 1695 |
|
|
2024
Q3 | $59M | Buy |
1,018,018
+2,451
| +0.2% | +$120K | ﹤0.01% | 1319 |
|
|
2024
Q2 | $41.2M | Buy |
1,015,567
+25,085
| +3% | +$995K | ﹤0.01% | 1483 |
|
|
2024
Q1 | $41.6M | Buy |
990,482
+46,033
| +5% | +$1.8M | ﹤0.01% | 1483 |
|
|
2023
Q4 | $36.2M | Buy |
944,449
+42,278
| +5% | +$1.41M | ﹤0.01% | 1541 |
|
|
2023
Q3 | $27.8M | Buy |
902,171
+40,348
| +5% | +$1.39M | ﹤0.01% | 1606 |
|
|
2023
Q2 | $27.2M | Buy |
861,823
+74,520
| +9% | +$2.56M | ﹤0.01% | 1654 |
|
|
2023
Q1 | $28.7M | Buy |
787,303
+30,007
| +4% | +$1.05M | ﹤0.01% | 1564 |
|
|
2022
Q4 | $22.4M | Buy |
757,296
+33,908
| +5% | +$1.09M | ﹤0.01% | 1699 |
|
|
2022
Q3 | $28.2M | Sell |
723,388
-8,154
| -1% | -$373K | ﹤0.01% | 1501 |
|
|
2022
Q2 | $28.2M | Buy |
731,542
+27,244
| +4% | +$1.04M | ﹤0.01% | 1510 |
|
|
2022
Q1 | $34.1M | Buy |
704,298
+31,438
| +5% | +$1.62M | ﹤0.01% | 1520 |
|
|
2021
Q4 | $49.4M | Buy |
672,860
+41,218
| +7% | +$3.39M | 0.01% | 1319 |
|
|
2021
Q3 | $57.5M | Buy |
631,642
+169,984
| +37% | +$14.5M | 0.01% | 1161 |
|
|
2021
Q2 | $29M | Buy |
461,658
+120,947
| +35% | +$4.47M | ﹤0.01% | 1713 |
|
|
2021
Q1 | $9.23M | Buy |
340,711
+39,152
| +13% | +$942K | ﹤0.01% | 2414 |
|
|
2020
Q4 | $5.51M | Buy |
301,559
+6,975
| +2% | +$125K | ﹤0.01% | 2551 |
|
|
2020
Q3 | $5.28M | Sell |
294,584
-24,887
| -8% | -$429K | ﹤0.01% | 2367 |
|
|
2020
Q2 | $5.27M | Buy |
319,471
+21,803
| +7% | +$343K | ﹤0.01% | 2317 |
|
|
2020
Q1 | $3.85M | Buy |
297,668
+17,349
| +6% | +$283K | ﹤0.01% | 2288 |
|
|
2019
Q4 | $5.16M | Sell |
280,319
-54,646
| -16% | -$906K | ﹤0.01% | 2429 |
|
|
2019
Q3 | $5.9M | Buy |
334,965
+113,526
| +51% | +$1.94M | ﹤0.01% | 2281 |
|
|
2019
Q2 | $3.7M | Buy |
221,439
+31,994
| +17% | +$581K | ﹤0.01% | 2586 |
|
|
2019
Q1 | $3.47M | Buy |
189,445
+6,000
| +3% | +$115K | ﹤0.01% | 2536 |
|
|
2018
Q4 | $3.64M | Buy |
183,445
+22,917
| +14% | +$429K | ﹤0.01% | 2422 |
|
|
2018
Q3 | $3.54M | Buy |
160,528
+95,686
| +148% | +$2.01M | ﹤0.01% | 2581 |
|
|
2018
Q2 | $1.68M | Buy |
+64,842
| New | +$1.11M | ﹤0.01% | 2955 |
|
Other funds holding ASTH
3C
Geode Capital Management's ASTH Position: Q2 2026 in Review
Geode Capital Management increased its Astrana Health (ASTH) stake by 13% in Q2 2026, buying an estimated $4.67M and bringing the position to 1,167,974 shares worth $54.2M. The position accounts for ﹤0.01% of the portfolio, ranked #1579.
Geode Capital Management first reported a position in ASTH in Q2 2018 and has held it in 33 quarters since. The position peaked at $59M in Q3 2024. 195 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.
- Geode Capital Management held 1,167,974 shares of Astrana Health worth $54.2M as of Q2 2026.
- Geode Capital Management bought 129,889 Astrana Health shares in Q2 2026, an estimated $4.67M.
- Astrana Health made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #1579 holding.
- Geode Capital Management first reported a position in Astrana Health in Q2 2018 and has held it in 33 quarters since.
- Geode Capital Management's Astrana Health position peaked at $59M in Q3 2024.
- 195 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.
Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.